Overview

The Effect of Sodium Zirconium Cyclosilicate on Albuminuria in Patients With Type 2 Diabetes and Hyperkalemia

Status:
Recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
To investigate whether concomitant treatment with Lokelma can improve the efficacy of standard blockade of the renin-angiotensin system in patients with type 2 diabetes, diabetic nephropathy and hyperkalemia.
Phase:
Phase 4
Details
Lead Sponsor:
Steno Diabetes Center Copenhagen
Collaborators:
AstraZeneca
Zealand University Hospital